Validation of the RBP‐9000c Oscillometric Blood Pressure Monitor in the General Population According to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/ International Organization for Standardization Un
The aim of this study was to evaluate the accuracy of the single upper-arm cuff oscillometric blood pressure (BP) monitor RBP-9000 c developed for office and home blood pressure measurement in the general population according to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (AAMI/ESH/ISO) Universal Standard (ISO 81060-2:2018). Subjects were recruited to fulfill the age, gender, BP, and cuff distribution criteria of the AAMI/ESH/ISO Universal Standard in the general population using the same-arm sequential BP measurement method. The test device incorporates a single built-in cuff suitable for 17-42 cm arm circumference. For validation criterion 1, the mean ± SD of the differences between the test device and reference BP readings was 2.4 ± 6.7/3.3 ± 6.3 mmHg (systolic/ diastolic). For criterion 2, the SD of the mean BP differences between the test device and reference BP per subject was 5.28/5.32 mmHg (systolic/diastolic). The RBP-9000c oscillometric device for office and home BP measurement fulfilled all the requirements of the AAMI/ESH/ISO Universal Standard (ISO 81060-2:2018) in the general population and can be recommended for clinical and self-use at home. Trial Registration: ChiCTR2300075747.
Authors
- Shijie Yang
- Zhanyang Zhou
- Miao He (ORCID: https://orcid.org/0000-0001-7494-5363)
- Yuqing Zhang
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing Anzhen Hospital (CN)
- Fu Wai Hospital (CN)
Publication Details
- Journal
- Journal of Clinical Hypertension
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1111/jch.70194
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00